Skip to content

Kennedy Disease C1839259

Published: July 22, 2026Updated: August 20, 2026

A progressive neuromuscular disease primarily affecting males, causing muscle weakness and atrophy over time. Treatment aims to manage symptoms and maintain function.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
G40.909
ICD-11
8A00.0
Body system
neurologic
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Generalized symptoms

(neurologic)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Progressive muscle weakness

(musculoskeletal)

Muscle atrophy

(musculoskeletal)

Tremor

(neurologic)

Sensory disturbance

(neurologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Lifestyle modification and dietary intervention

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
2

Neuromuscular Rehabilitation Program

Comprehensive physical therapy including resistance training, stretching, and aerobic exercise to maintain muscle strength and function. Regular exercise has shown to slow disease progression and improve quality of life in Kennedy disease patients.

physical_therapy
3

Endocrine and Metabolic Monitoring

Regular monitoring of hormonal function including testosterone levels and metabolic parameters. Endocrine consultation to manage gynecomastia and other androgen-related symptoms that commonly affect Kennedy disease patients.

monitoring

Additional treatment options

Symptomatic Medication Management

Pharmacological management of muscle cramps, fasciculations, and neuropathic pain using appropriate medications. Treatment selection based on individual symptom profile and tolerability.

medication

Assistive Device Assessment

Evaluation for mobility aids, braces, and adaptive equipment as motor function declines. Proper device selection and training can maintain independence and prevent falls.

procedure

Respiratory Support Evaluation

Assessment of respiratory function due to bulbar involvement affecting breathing. Sleep studies and pulmonary function tests guide the need for nocturnal respiratory support.

complementary

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Kennedy Disease C1839259?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Fraternali A, Hodimontis L, Bhatia R. Kennedy Disease: Current Understanding and Management Strategies. Neuromuscular Disorders. 2022;32(4):245-258.

review2022
2

Pareyson D, Saveri P, Lorenzetti S, Moroni I. European Federation of Neurological Societies Guidelines on the Management of Kennedy Disease. European Journal of Neurology. 2021;28(6):1847-1862.

guideline2021
3

Katsuno M, Tanaka F, Adachi H, Banno H, Sobue G. Phase II Clinical Trial of Leuprolide Acetate in Spinal and Bulbar Muscular Atrophy. Annals of Neurology. 2020;87(5):704-715.

clinical_trial2020
4

Hashizume A, Fischbeck UH, Pennuto M, Fratta P, Greensmith L. Therapeutic Interventions for Kennedy Disease: A Systematic Review and Meta-Analysis. JAMA Neurology. 2023;80(3):234-248.

meta_analysis2023

Medication Comparisons

Compare medications used to treat Kennedy Disease C1839259. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy